Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan

Annals of the Rheumatic Diseases

Volumn 65, Issue 12, 2006, Pages 1664-

  Dowman, J K ^a   Khattak, F H ^a  

^a SANDWELL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; ISOTOPE; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ANAMNESIS; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; HORMONE BLOOD LEVEL; HUMAN; HYPOPHOSPHATEMIA; MALE; OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; OSTEOMALACIA; PARANEOPLASTIC SYNDROMES;

EID: 33751303564     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.057943     Document Type: Article

References (5)

1. Fukomoto S, Takeuchi Y, Nagano A, Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 1999;25:375-7.
2. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004;19:429-35.
3. Carpenter T. Oncogenic osteomalacia - a complex dance of factors. N Engl J Med 2003;348:1705-8.
4. Lyles KW, Berry WR, Haussler M, Herrelson JM, Drezner MK. Hypophosphataemic osteomalacia: association with prostatic carcinoma. Ann Intern Med 1980;93:275-8.
5. Stewart I, Roddie C, Gill A, Clarkson A, Mirams M, Nelson A. Elevated serum FGF23 concentrations in plasma cell dyscrasias. J Bone Mineral Res 2005;20:S116.